These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8632910)
1. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation. Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910 [TBL] [Abstract][Full Text] [Related]
2. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Li CY; Nagasawa H; Dahlberg WK; Little JB Oncogene; 1995 Nov; 11(9):1885-92. PubMed ID: 7478618 [TBL] [Abstract][Full Text] [Related]
3. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related]
4. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511 [TBL] [Abstract][Full Text] [Related]
5. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049 [TBL] [Abstract][Full Text] [Related]
6. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression. Linke SP; Harris MP; Neugebauer SE; Clarkin KC; Shepard HM; Maneval DC; Wahl GM Oncogene; 1997 Jul; 15(3):337-45. PubMed ID: 9233768 [TBL] [Abstract][Full Text] [Related]
7. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein. Cajot JF; Anderson MJ; Lehman TA; Shapiro H; Briggs AA; Stanbridge EJ Cancer Res; 1992 Dec; 52(24):6956-60. PubMed ID: 1458487 [TBL] [Abstract][Full Text] [Related]
8. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668 [TBL] [Abstract][Full Text] [Related]
9. p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles. Rand A; Glenn KS; Alvares CP; White MB; Thibodeau SM; Karnes WE Cancer Lett; 1996 Jan; 98(2):183-91. PubMed ID: 8556707 [TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Joyce NC; Navon SE; Roy S; Zieske JD Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1566-75. PubMed ID: 8675399 [TBL] [Abstract][Full Text] [Related]
11. Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins. Steegenga WT; Van Laar T; Shvarts A; Terleth C; Van der Eb AJ; Jochemsen AG Virology; 1995 Oct; 212(2):543-54. PubMed ID: 7571424 [TBL] [Abstract][Full Text] [Related]
12. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization. Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743 [TBL] [Abstract][Full Text] [Related]
13. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Matsui SI; Arredondo MA; Wrzosek C; Rustum YM Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989 [TBL] [Abstract][Full Text] [Related]
14. p53 protein accumulation in addition to the transactivation activity is required for p53-dependent cell cycle arrest after treatment of cells with camptothecin. Jaks V; Jõers A; Kristjuhan A; Maimets T Oncogene; 2001 Mar; 20(10):1212-9. PubMed ID: 11313865 [TBL] [Abstract][Full Text] [Related]
15. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53. Vikhanskaya F; Erba E; D'Incalci M; Broggini M Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577 [TBL] [Abstract][Full Text] [Related]
16. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719 [TBL] [Abstract][Full Text] [Related]
17. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine. Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599 [TBL] [Abstract][Full Text] [Related]
18. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Saied IT; Shamsuddin AM Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359 [TBL] [Abstract][Full Text] [Related]
20. Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells. Kramer DL; Vujcic S; Diegelman P; Alderfer J; Miller JT; Black JD; Bergeron RJ; Porter CW Cancer Res; 1999 Mar; 59(6):1278-86. PubMed ID: 10096560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]